2.06 USD
▼+0.49-2.83%
盘后 2.12 -0.08%
2026-08-03
市值
$87.01M
市盈率
—
EPS
-1.15
股息率
—
52 周区间
1.13 – 2.89
成交量
1.06M
Beta
0.31
目标价
3.40
52W 低 1.1352W 高 2.89
价格走势
公司简介
Pulmonx Corporation, a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease. It offers Zephyr Endobronchial Valve; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. The company also offers LungTraX Platform, a cloud-based quantitative computed tomography analysis service that provides physicians with mult...